A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus

Authors: Korytkowski M.¹; Bell D.; Jacobsen C.; Suwannasari R.; FlexPenR Study Team

Source: Clinical Therapeutics, Volume 25, Number 11, November 2003 , pp. 2836-2848(13)

Publisher: Elsevier

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Keywords: insulin aspart; diabetes mellitus; insulin pens; vial and syringe; insulin delivery systems; quality of life; compliance; FlexPen(R)

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(03)80337-5

Affiliations: 1: Department of Medicine, Endocrinology, and Metabolism, University of Pittsburgh Medical Center, , Pittsburgh, Pennsylvania, USA

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.

Tools

Need to register?
Sign up here

Text size: A | A | A | A